首页> 外国专利> The use of a variant of polipeptu00ecdeo interferon beta (IFNb), and methods for treating or preventing stroke or cerebrovascular accident (CVA) and ischemic attack in a primate

The use of a variant of polipeptu00ecdeo interferon beta (IFNb), and methods for treating or preventing stroke or cerebrovascular accident (CVA) and ischemic attack in a primate

机译:ept肽干扰素β(IFNb)变体的用途以及在灵长类动物中治疗或预防中风或脑血管意外(CVA)和缺血性发作的方法

摘要

The use of a variant of polipeptu00ecdeo interferon beta (IFNb), and methods for treating or preventing stroke or cerebrovascular accident (CVA) and ischemic attack in a primate. The present invention relates to the use of polypeptides similar to interferon beta for the treatment of stroke or transient ischemic attack in a primate, preferably on a human being.More particularly, the polypeptides similar to interferon beta differs from the sequ00b3u00eancia IFNb amino acid of human wild type (SEQ ID No: 2) in which at least one glycosylation site.Preferably at least one place of N - glycosylation in vivo was u00edntroduzido. Optionally the polypeptides similar to pegylated interferon beta are
机译:lip肽干扰素β(IFNb)变体的用途,以及在灵长类动物中治疗或预防中风或脑血管意外(CVA)和缺血性发作的方法。本发明涉及类似于干扰素β的多肽在灵长类动物中,优选对人的中风或短暂性脑缺血发作的治疗中的用途。更具体地,类似于干扰素β的多肽不同于seq u00b3 u00eancia人野生型的IFNb氨基酸(SEQ ID No:2),其中至少一个糖基化位点。体内至少N-糖基化的至少一个位置是edrodroduzido。任选地,类似于聚乙二醇化干扰素β的多肽是

著录项

  • 公开/公告号BR0308322A

    专利类型

  • 公开/公告日2004-12-21

    原文格式PDF

  • 申请/专利权人 MAXYGEN APS;

    申请/专利号BR20030308322

  • 发明设计人 STEVEN GLAZER;THOMAS SAGER;

    申请日2003-02-28

  • 分类号A61K38/21;

  • 国家 BR

  • 入库时间 2022-08-21 22:18:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号